These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 6133664)
21. [Comparative pharmacokinetics of 5 hypnotic benzodiazepines in healthy volunteers]. Jochemsen R; Van Boxtel CJ; Breimer DD Nouv Presse Med; 1982 Oct; 11(40):2965-6. PubMed ID: 6128720 [TBL] [Abstract][Full Text] [Related]
22. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam. Masica AL; Mayo G; Wilkinson GR Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333 [TBL] [Abstract][Full Text] [Related]
23. Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administration. Jochemsen R; van Rijn PA; Hazelzet TG; van Boxtel CJ; Breimer DD Biopharm Drug Dispos; 1986; 7(1):53-61. PubMed ID: 2869795 [TBL] [Abstract][Full Text] [Related]
24. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam. Smith RB; Divoll M; Gillespie WR; Greenblatt DJ J Clin Psychopharmacol; 1983 Jun; 3(3):172-6. PubMed ID: 6135721 [No Abstract] [Full Text] [Related]
25. Pharmacokinetics of temazepam compared with other benzodiazepine hypnotics--some clinical consequences. Jochemsen R; Breimer DD Acta Psychiatr Scand Suppl; 1986; 332():20-31. PubMed ID: 2883825 [TBL] [Abstract][Full Text] [Related]
26. Is temazepam an accumulating hypnotic? Ochs HR; Greenblatt DJ; Heuer H J Clin Pharmacol; 1984 Jan; 24(1):58-64. PubMed ID: 6142905 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam. Yuan R; Flockhart DA; Balian JD J Clin Pharmacol; 1999 Nov; 39(11):1109-25. PubMed ID: 10579141 [TBL] [Abstract][Full Text] [Related]
28. [Significance of pharmacokinetic findings for the clinical effect of benzodiazepines]. Horowski R; Dorow R Internist (Berl); 1982 Nov; 23(11):632-40. PubMed ID: 6130052 [No Abstract] [Full Text] [Related]
30. Pharmacokinetics and the sedative effect of midazolam. Kanto J; Allonen H Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):460-3. PubMed ID: 6138314 [TBL] [Abstract][Full Text] [Related]
31. Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures. Horowski R J Neural Transm (Vienna); 2020 Aug; 127(8):1107-1115. PubMed ID: 32468272 [TBL] [Abstract][Full Text] [Related]
32. Relative bioavailability in humans for oral tablets and solutions of lormetazepam. Zecca L; Reina L; Scaglione F; Ferrario P; Pirola R; Ceccarelli G; Ciampini M; Fraschini F Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milk. Seyberth HW Eur J Clin Pharmacol; 1983; 24(1):139-40. PubMed ID: 6131824 [No Abstract] [Full Text] [Related]
34. [Screening, detection and biotransformation of lormetazepam, a new hypnotic agent from the 1,4-benzodiazepine series (author's transl)]. Schütz H; Fitz H Arzneimittelforschung; 1982; 32(3):177-83. PubMed ID: 6123328 [TBL] [Abstract][Full Text] [Related]
35. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Ellinwood EH; Heatherly DG; Nikaido AM; Bjornsson TD; Kilts C Psychopharmacology (Berl); 1985; 86(4):392-9. PubMed ID: 2863843 [TBL] [Abstract][Full Text] [Related]